A prolific investor in Florida banks put up $40 million in the recapitalization and will take a seat on BayFirst's board of ...
Alector has stopped another Alzheimer's drug clinical trial. This is the third failure in 18 months. Here's how the biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results